Drug Approval | August 26, 2021
Wockhardt and Jemincare partner for novel respiratory antibiotic Nafithromycin
The company to receive upfront and milestone payments, in addition to royalties
The company to receive upfront and milestone payments, in addition to royalties
BD worked with JCI to create a Gold Standard benchmarked safety program called Preventing Risks of Infections and Medication Errors in IV Therapy (PRIME)
Surgeries for the replacement of hip and knee joints have become common, the ones for the replacement of jaw joints and the use of 3D printed custom-made joints are new
Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients four years of age and older
Domestic market and developing countries will need doses of Indian vaccines
Asia-Pacific is projected to portray the fastest CAGR of 13.2 by 2030
A new market study published by Global Industry Analysts (GIA), released its report titled, ``Healthcare Supply Chain Management—Global Market Trajectory & Analytics.’’ We present excerpts from the report
The healthcare vertical is US-focused, has 35-plus clients and 24,000 employees across 34 locations in five countries
Both companies aim to improve the efficiency and success rate of the current drug discovery process.
The transaction is expected to close in the Q4FY22
Subscribe To Our Newsletter & Stay Updated
